Genes & Immunity - Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases Skip to main content Thank you for visiting nature.com.

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. ... The sixth dose of interleukin-2 was not given owing to hypotension that led to the use of vasopressor support with phenylephrine ...

Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med 2021;384:1491-1502. Crossref. PubMed. Web of Science. Google Scholar. 4.

Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement. The ...

Researchers from Japan identify the role of interleukin-36 receptor antagonists in healing skin wounds from ischemia-reperfusion injuries Date: November 8, 2021 Source: Fujita Health University ...

Lassen Therapeutics Commences Dosing in Phase 1 Clinical Study of LASN01, a First-in-Class Interleukin-11 Receptor-Blocking Antibody. LASN01 targets the immunological drivers of fibrosis; ...

For patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published in the Feb. 8 ...